09:30~10:00  등록

10:00-10:10   개회사                                       회장 심영목(식도암연구회)

Session I.  Molecular characteristics and diagnosis of esophageal cancer

10:10-10:30  Epigenetic alteration as a prognostic indicator of esophageal cancer                  

- 김덕환  (성균관의대 분자세포생물학과)

10:30-10:50  Gene analysis of esophageal cancer

                                                               - 이해원   (원자력병원 흉부외과)

10:50-11:10  Role of endoscopy and EUS in esophageal cancer 

- 이진혁  (울산의대 소화기내과)

11:10-11:30  Role of  FDG-PET in esophageal cancer

- 천기정 (원자력병원 핵의학과)

11:30-11:50   Panel  Discussion      좌장; 심찬섭 (순천향의대), 이경수(성균관의대)

11:50-13:00  Lunch

Session II. Therapeutic advances in combined treatment for esophageal cancer

13:00-13:20  Preoperative chemoradiotherapy of esophageal cancer

- 김성배   (울산의대 혈액종양내과)

13:20-13:40  Adjuvant chemotherapy of esophageal cancer

- 임영혁   (성균관의대 혈액종양내과)

13:40-14:00  Concurrent chemoradiotherapy for unresectable esophageal cancer

- 김종훈   (울산의대 방사선종양학과)

14:00-14:30   Non surgical approach in resectable esophageal cancer

- Dr Boku (Shixoka Cancer Center)

14:30-14:50 Panel Discussion          좌장; 김흥태(국립암센터), 안용찬(성균관의대)

14:50-15:10  Coffee Break

Session III. Surgical treatment of esophageal cancer  

15:10-15:30  Esophageal reconstruction-introduction

- 조재일  (국립암센터 폐암센터)

15:30-15:50  Role of lymph node dissection in esophageal cancer

- 박종호   (원자력병원 흉부외과)

15:50-16:10  Prevention and management of postoperative complication

- 박승일   (울산의대 흉부외과)

16:10-16:30  Quality of life after esophagectomy

- 심영목   (성균관의대 흉부외과)

16:30-17:00  Current status of esophageal cancer – Japanese point of view

- Dr. Hiromasa Fujita

17:00-!7:20  Panel Discussion           좌장; 김광택(고려의대), 성숙환(서울의대)

17:20-17:30       폐회사